Modification of Allergic Immunologic Response by Leukotriene Antagonists - Ancillary to ACRN IMPACT
NCT00021931 · Status: COMPLETED · Type: OBSERVATIONAL
Last updated 2016-03-16
Summary
To examine the cellular and molecular mechanisms of corticosteroid and leukotriene receptor antagonists, focusing on their effects on T lymphocytes during both chronic (18 months) and acute therapy.
Conditions
- Asthma
- Lung Diseases
Sponsors & Collaborators
-
Asthma Clinical Research Network
collaborator NETWORK -
National Heart, Lung, and Blood Institute (NHLBI)
lead NIH
Principal Investigators
-
Patricia Finn · Brigham and Women's Hospital
Eligibility
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2001-04-30
- Completion
- 2005-03-31
More Related Trials
-
Blood Leukocyte Profiling in Eosinophilic Type 2 Asthma: Influence of Systemic IL-5 Targeting
NCT05689931 ·Status: UNKNOWN
-
Observational and Epidemiologic Study of the Disease Course and Unmet Needs in Children With Symptomatic Moderate to Severe Allergic Asthma
NCT01362621 ·Status: COMPLETED
-
Leukotriene D4 Bronchial Provocation Test (LTD4-BPT) as an Indicator for the Use of Leukotriene Receptor Antagonist (LTRA)
NCT01414868 ·Status: COMPLETED ·Phase: NA
-
Immune Dysregulation in Children and Adults With Asthma
NCT00135681 ·Status: COMPLETED ·Phase: NA
-
Airway Immune Response to Allergens (Use Lay Language Here)
NCT04619017 ·Status: UNKNOWN ·Phase: PHASE1
-
Effects of Montelukast in Children With Asthma
NCT00675285 ·Status: COMPLETED ·Phase: PHASE3
-
Asthma Clinical Research Network (ACRN)
NCT00000577 ·Status: WITHDRAWN ·Phase: PHASE3
-
T Cell Effector and Regulatory Mechanisms in Asthma
NCT01612936 ·Status: COMPLETED ·Phase: PHASE1
-
Study of the Mechanisms of Asthma
NCT00595153 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Biologicals on Alternative Functions of Eosinophils in Severe Asthma
NCT04520165 ·Status: ACTIVE_NOT_RECRUITING
-
Isocyanate Antigens and T Cells That Cause Asthma
NCT00005549 ·Status: COMPLETED
-
A Mechanistic Study to Evaluate the Efficacy of Montelukast on Airway Function in Asthma
NCT01841164 ·Status: UNKNOWN ·Phase: NA
-
Distribution of Neutrophils in Bronchial Mucosal Tissue in Asthma Patients Before and After 4 Weeks Treatment With AZD 5069
NCT01890148 ·Status: COMPLETED ·Phase: PHASE1
-
No Resistance After Long Term Treatment SERETIDE
NCT00456313 ·Status: WITHDRAWN ·Phase: PHASE4
-
Risk Factors For Asthma in Laboratory Animal Allergy
NCT00005283 ·Status: COMPLETED
-
Effect of Montelukast on the Airway Remodeling
NCT00699062 ·Status: COMPLETED ·Phase: PHASE4
-
Leukotriene Polymorphisms and Montelukast Response - Ancillary to LoDo Trial
NCT00046644 ·Status: COMPLETED
-
Clinical Relevance of Small Airways Disease in Severe Asthma Patients Treated With Anti-InterLeukin-5 Therapy
NCT05706597 ·Status: UNKNOWN
-
Efficacy and Safety Study of Benralizumab Added to High-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma
NCT01928771 ·Status: COMPLETED ·Phase: PHASE3
-
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
NCT00576069 ·Status: RECRUITING
-
TNF Alpha in Refractory Asthma
NCT00276029 ·Status: COMPLETED ·Phase: NA
-
Towards Targeting the ORigin of the Inflammatory Cascade in Allergic Asthma
NCT04264377 ·Status: UNKNOWN
-
Effect of Add-on Montelukast to Inhaled Corticosteroids on Airway Responsiveness
NCT00913328 ·Status: COMPLETED ·Phase: PHASE4
-
Does Montelukast Have an Affect on the Function of the Artery in Patients With Heart Disease
NCT00351364 ·Status: TERMINATED ·Phase: PHASE4
-
Development of a Novel Non-invasive Inflammometry Following Allergen Challenge in Patients With Mild Allergic Asthma
NCT06317909 ·Status: RECRUITING ·Phase: NA